Extracellular Vesicles and Circulating Nucleic Acids Journal Pubishes New Article from Prof. Andrew Godwin

The Extracellular Vesicles and Circulating Nucleic Acids Journal has published a new article from Prof. Godwin and his colleagues at the University of Kansas Medical Center on "The multifaceted roles of extracellular vesicles for therapeutic intervention with non-Hodgkin lymphoma."

Abstract

Extracellular vesicles (EVs) contribute to the development of cancer in various ways. Non-Hodgkin lymphoma (NHL) is a cancer of mature lymphocytes and the most common hematological malignancy globally. The most common form of NHL, diffuse large B-cell lymphoma (DLBCL), is primarily treated with chemotherapy, autologous stem cell transplantation (ASCT), and/or chimeric antigen receptor T-cell (CAR-T) therapy. With NHL disease progression and its treatment, extracellular vesicles play remarkable roles in influencing outcomes. This finding can be utilized for therapeutic intervention to improve patient outcomes for NHL. This review focuses on the multifaceted roles of EVs with NHL and its potential for guiding patient care.